Curis Lifesciences Charts a New Growth Path with Uninova, Export Markets and Branded Pharma Expansion

Curis Lifesciences Charts a New Growth Path with Uninova, Export Markets and Branded Pharma Expansion

Curis Lifesciences Charts a New Growth Path with Uninova, Export Markets and Branded Pharma Expansion

Market: Curis acquire 51% of Uninova

Patel focused on building a diversified pharmaceutical platform Ahmedabad’s Curis Lifesciences Limited is entering a new phase of growth as it expands across domestic branded pharmaceuticals, international markets and contract manufacturing, with its 51% acquisition of Gujarati-owned Uninova Lifesciences Pvt Ltd, adding a new dimension to the company’s evolving business strategy. The company’s growth roadmap […] Source